中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
18期
6-7,41
,共3页
长期住院%慢性精神分裂症%氯氮平%利培酮%联合
長期住院%慢性精神分裂癥%氯氮平%利培酮%聯閤
장기주원%만성정신분렬증%록담평%리배동%연합
Long-Term Hospitalization%Chronic Schizophrenia%Clozapine%Risperidone%Combination
目的::观察长期住院服用氯氮平治疗的慢性精神分裂症患者合用利培酮治疗后的疗效及不良反应。方法:对40例长期住院并服用氯氮平治疗的慢性精神分裂症患者联合使用利培酮治疗,治疗前,治疗后4、8、12周末,采用阳性症状和阴性症状量表(PANSS )进行疗效评定,采用不良反应量表(TESS )、锥体外系症状评定量表(ESRS)及有关实验室检查记录对患者药物不良反应例数。结果:联合使用利培酮后患者的治疗有效率为22.5%,治疗前后 PANSS 量表总分、阳性量表分、一般精神病理量表分差异有统计学意义(P<0.05),PANSS 量表阴性量表分差异无统计学意义(P>0.05),治疗后患者的不良反应例数减少。结论:对于长期住院服用氯氮平的患者,氯氮平和利培酮联用对患者的阳性症状及一般精神病理症状能有所改善,对阴性症状改善不明显,总体有效率不高,但能减少氯氮平使用剂量,降低不良反应的发生率。
目的::觀察長期住院服用氯氮平治療的慢性精神分裂癥患者閤用利培酮治療後的療效及不良反應。方法:對40例長期住院併服用氯氮平治療的慢性精神分裂癥患者聯閤使用利培酮治療,治療前,治療後4、8、12週末,採用暘性癥狀和陰性癥狀量錶(PANSS )進行療效評定,採用不良反應量錶(TESS )、錐體外繫癥狀評定量錶(ESRS)及有關實驗室檢查記錄對患者藥物不良反應例數。結果:聯閤使用利培酮後患者的治療有效率為22.5%,治療前後 PANSS 量錶總分、暘性量錶分、一般精神病理量錶分差異有統計學意義(P<0.05),PANSS 量錶陰性量錶分差異無統計學意義(P>0.05),治療後患者的不良反應例數減少。結論:對于長期住院服用氯氮平的患者,氯氮平和利培酮聯用對患者的暘性癥狀及一般精神病理癥狀能有所改善,對陰性癥狀改善不明顯,總體有效率不高,但能減少氯氮平使用劑量,降低不良反應的髮生率。
목적::관찰장기주원복용록담평치료적만성정신분렬증환자합용리배동치료후적료효급불량반응。방법:대40례장기주원병복용록담평치료적만성정신분렬증환자연합사용리배동치료,치료전,치료후4、8、12주말,채용양성증상화음성증상량표(PANSS )진행료효평정,채용불량반응량표(TESS )、추체외계증상평정량표(ESRS)급유관실험실검사기록대환자약물불량반응례수。결과:연합사용리배동후환자적치료유효솔위22.5%,치료전후 PANSS 량표총분、양성량표분、일반정신병리량표분차이유통계학의의(P<0.05),PANSS 량표음성량표분차이무통계학의의(P>0.05),치료후환자적불량반응례수감소。결론:대우장기주원복용록담평적환자,록담평화리배동련용대환자적양성증상급일반정신병리증상능유소개선,대음성증상개선불명현,총체유효솔불고,단능감소록담평사용제량,강저불량반응적발생솔。
Objective:To observe curative effects and adverse reactions of Risperidone combined with Clozapine in treatment of long-term hospitalization chronic schizophrenics, who had taken Clozapine for a long time. Methods:40 long-term hospitalization chronic schizophrenics took Risperidone based on Clozapine. Before and 4, 8, and 12 weeks after the treatment, positive and negative syndrome scale (PANSS) was applied for the evaluation of curative effects; treatment emergent symptom scale (TESS), Extrapyramid-al symptom rating scale (ESRS), as well as the relevant laboratory examination record of the number of cases were used to access the adverse drug reactions. Results: The effective rate of Risperidone combined with Clozapine was 22. 5% . There were statistical differ-ences in the PANSS total score, positive symptom scale score, and general psychopathology scale score before and after the treatment (P<0. 05), however, there was no statistical difference in the negative symptom scale score before and after the treatment (P>0. 05). After the treatment, the number of the cases of the adverse reactions decreased. Conclusions: For the long-term hospitalization chronic schizophrenics, Risperidone combined with Clozapine can improve the positive symptoms and general psychopathological symptoms, but can not improve the negative symptoms. Although Risperidone combined with Clozapine does not have a high total effective rate, it can reduce the dosage of Clozapine and decrease the occurrence rate of the adverse reactions.